118 related articles for article (PubMed ID: 35460832)
61. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells.
Aryal P; Kim K; Park PH; Ham S; Cho J; Song K
FEBS J; 2014 Oct; 281(20):4644-58. PubMed ID: 25132405
[TBL] [Abstract][Full Text] [Related]
62. CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.
Chen RQ; Yang QK; Lu BW; Yi W; Cantin G; Chen YL; Fearns C; Yates JR; Lee JD
Cancer Res; 2009 Mar; 69(6):2663-8. PubMed ID: 19276368
[TBL] [Abstract][Full Text] [Related]
63. Dynamic modeling of signal transduction by mTOR complexes in cancer.
Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
[TBL] [Abstract][Full Text] [Related]
64. The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway.
Tamaddoni A; Mohammadi E; Sedaghat F; Qujeq D; As'Habi A
Pharmacol Res; 2020 Jun; 156():104798. PubMed ID: 32278045
[TBL] [Abstract][Full Text] [Related]
65. Hyperglycemia-induced Bcl-2/Bax-mediated apoptosis of Schwann cells via mTORC1/S6K1 inhibition in diabetic peripheral neuropathy.
Zhu L; Hao J; Cheng M; Zhang C; Huo C; Liu Y; Du W; Zhang X
Exp Cell Res; 2018 Jun; 367(2):186-195. PubMed ID: 29621478
[TBL] [Abstract][Full Text] [Related]
66. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
[TBL] [Abstract][Full Text] [Related]
67. Folic acid supplementation at lower doses increases oxidative stress resistance and longevity in Caenorhabditis elegans.
Rathor L; Akhoon BA; Pandey S; Srivastava S; Pandey R
Age (Dordr); 2015 Dec; 37(6):113. PubMed ID: 26546011
[TBL] [Abstract][Full Text] [Related]
68. Integrative proteomic and phosphoproteomic profiling of invasive micropapillary breast carcinoma.
Chen X; Lin Y; Jin X; Zhang W; Guo W; Chen L; Chen M; Li Y; Fu F; Wang C
J Proteomics; 2022 Apr; 257():104511. PubMed ID: 35139397
[TBL] [Abstract][Full Text] [Related]
69. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
70. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
71. Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction.
Kakiuchi Y; Yurube T; Kakutani K; Takada T; Ito M; Takeoka Y; Kanda Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2019 Jun; 27(6):965-976. PubMed ID: 30716534
[TBL] [Abstract][Full Text] [Related]
72. Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model.
Lamming DW; Cummings NE; Rastelli AL; Gao F; Cava E; Bertozzi B; Spelta F; Pili R; Fontana L
Oncotarget; 2015 Oct; 6(31):31233-40. PubMed ID: 26378060
[TBL] [Abstract][Full Text] [Related]
73. Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer.
Hampsch RA; Shee K; Bates D; Lewis LD; Désiré L; Leblond B; Demidenko E; Stefan K; Huang YH; Miller TW
Oncotarget; 2017 Mar; 8(13):21806-21817. PubMed ID: 28423521
[TBL] [Abstract][Full Text] [Related]
74. High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.
Yellen P; Saqcena M; Salloum D; Feng J; Preda A; Xu L; Rodrik-Outmezguine V; Foster DA
Cell Cycle; 2011 Nov; 10(22):3948-56. PubMed ID: 22071574
[TBL] [Abstract][Full Text] [Related]
75. A novel rapamycin analog is highly selective for mTORC1 in vivo.
Schreiber KH; Arriola Apelo SI; Yu D; Brinkman JA; Velarde MC; Syed FA; Liao CY; Baar EL; Carbajal KA; Sherman DS; Ortiz D; Brunauer R; Yang SE; Tzannis ST; Kennedy BK; Lamming DW
Nat Commun; 2019 Jul; 10(1):3194. PubMed ID: 31324799
[TBL] [Abstract][Full Text] [Related]
76. Bovine lactoferrin induces cell cycle arrest and inhibits mTOR signaling in breast cancer cells.
Zhang Y; Nicolau A; Lima CF; Rodrigues LR
Nutr Cancer; 2014; 66(8):1371-85. PubMed ID: 25356800
[TBL] [Abstract][Full Text] [Related]
77. Mammalian target of rapamycin controls glucose consumption and redox balance in human Sertoli cells.
Jesus TT; Oliveira PF; Silva J; Barros A; Ferreira R; Sousa M; Cheng CY; Silva BM; Alves MG
Fertil Steril; 2016 Mar; 105(3):825-833.e3. PubMed ID: 26698679
[TBL] [Abstract][Full Text] [Related]
78. Phosphoproteomic profiling of in vivo signaling in liver by the mammalian target of rapamycin complex 1 (mTORC1).
Demirkan G; Yu K; Boylan JM; Salomon AR; Gruppuso PA
PLoS One; 2011; 6(6):e21729. PubMed ID: 21738781
[TBL] [Abstract][Full Text] [Related]
79. Investigation of the effects of rapamycin on the mTOR pathway and apoptosis in metastatic and non-metastatic human breast cancer cell lines.
Ekizceli G; Uluer ET; Inan S
Bratisl Lek Listy; 2020; 121(4):308-315. PubMed ID: 32356448
[TBL] [Abstract][Full Text] [Related]
80. Nutrient signaling to mTOR and cell growth.
Jewell JL; Guan KL
Trends Biochem Sci; 2013 May; 38(5):233-42. PubMed ID: 23465396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
